drugset / Trial / NCT04813705
18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma
Phase 2
Recruiting
93 enrolled
Taizhou Hospital
Taizhou Cancer Hospital · collabTaizhou Enze Medical Center Group · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to explore whether 18F-FDG PET/CT guided reduced-dose radiotherapy would maintain survival outcomes in nasopharyngeal carcinoma (NPC) patients.
Timeline
- Start
- 2022-01-01
- Primary completion
- 2024-06-30
- Completion
- 2029-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Cisplatin | Other / unclassified | — | — |